Market revenue in 2023 | USD 271.5 million |
Market revenue in 2030 | USD 755.2 million |
Growth rate | 15.7% (CAGR from 2023 to 2030) |
Largest segment | Ctms |
Fastest growing segment | ECOA |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | ECOA, EDC & CDMS, Clinical Analytics Platforms, Clinical Data Integration Platforms, Safety solutions, CTMS, RTSM, ETMF, EConsent |
Key market players worldwide | DATATRAK International Inc, Oracle Corp, PAREXEL, Dassault Systemes SE, Signant Health, Clario, eClinicalWorks, International Business Machines Corp, IQVIA Holdings Inc, Veeva Systems Inc Class A, Anju Software, MaxisIT Inc., Castor |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to eclinical solutions market will help companies and investors design strategic landscapes.
Ctms was the largest segment with a revenue share of 19.48% in 2023. Horizon Databook has segmented the Spain eclinical solutions market based on ecoa, edc & cdms, clinical analytics platforms, clinical data integration platforms, safety solutions, ctms, rtsm, etmf, econsent covering the revenue growth of each sub-segment from 2018 to 2030.
Spain has Spanish National Health Services and Autonomous Communities (AC’s) registered in accordance with the law for regulating clinical trials. The market for eClinical services in this region is anticipated to witness lucrative growth over the forecast period. This region is expected to grow at a moderate rate over the forecast period owing to favorable healthcare infrastructure.
The pharmaceutical sector based in the country promotes eight out of ten clinical trials and allocates 60% of all R&D investment for new medicines. As stated by the latest R&D Activities Survey that conducted by Farmaindustria annually amongst its associates, of the USD 1368.20 million that was invested in 2019 - more than USD 805.55 million was dedicated to clinical trials. Thus, contributes to overall market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain eclinical solutions market , including forecasts for subscribers. This country databook contains high-level insights into Spain eclinical solutions market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account